204 related articles for article (PubMed ID: 26880453)
21. Overexpression of BCLXL in Osteoblasts Inhibits Osteoblast Apoptosis and Increases Bone Volume and Strength.
Moriishi T; Fukuyama R; Miyazaki T; Furuichi T; Ito M; Komori T
J Bone Miner Res; 2016 Jul; 31(7):1366-80. PubMed ID: 26852895
[TBL] [Abstract][Full Text] [Related]
22. Osteoblast-Specific Overexpression of Human WNT16 Increases Both Cortical and Trabecular Bone Mass and Structure in Mice.
Alam I; Alkhouli M; Gerard-O'Riley RL; Wright WB; Acton D; Gray AK; Patel B; Reilly AM; Lim KE; Robling AG; Econs MJ
Endocrinology; 2016 Feb; 157(2):722-36. PubMed ID: 26584014
[TBL] [Abstract][Full Text] [Related]
23. Only minor differences in renal osteodystrophy features between wild-type and sclerostin knockout mice with chronic kidney disease.
Cejka D; Parada-Rodriguez D; Pichler S; Marculescu R; Kramer I; Kneissel M; Gross T; Reisinger A; Pahr D; Monier-Faugere MC; Haas M; Malluche HH
Kidney Int; 2016 Oct; 90(4):828-34. PubMed ID: 27528549
[TBL] [Abstract][Full Text] [Related]
24. Endogenous parathyroid hormone-related protein compensates for the absence of parathyroid hormone in promoting bone accrual in vivo in a model of bone marrow ablation.
Zhu Q; Zhou X; Zhu M; Wang Q; Goltzman D; Karaplis A; Miao D
J Bone Miner Res; 2013 Sep; 28(9):1898-911. PubMed ID: 23716486
[TBL] [Abstract][Full Text] [Related]
25. Overexpression of Gα
Zhang L; Sugamori KS; Claridge C; Dela Cruz A; Grynpas MD; Mitchell J
J Bone Miner Res; 2017 Nov; 32(11):2171-2181. PubMed ID: 28727179
[TBL] [Abstract][Full Text] [Related]
26. RGS18 acts as a negative regulator of osteoclastogenesis by modulating the acid-sensing OGR1/NFAT signaling pathway.
Iwai K; Koike M; Ohshima S; Miyatake K; Uchiyama Y; Saeki Y; Ishii M
J Bone Miner Res; 2007 Oct; 22(10):1612-20. PubMed ID: 17576169
[TBL] [Abstract][Full Text] [Related]
27. Stimulation of fibroblast growth factor 23 by metabolic acidosis requires osteoblastic intracellular calcium signaling and prostaglandin synthesis.
Krieger NS; Bushinsky DA
Am J Physiol Renal Physiol; 2017 Oct; 313(4):F882-F886. PubMed ID: 28298360
[TBL] [Abstract][Full Text] [Related]
28. Metabolic acidosis stimulates RANKL RNA expression in bone through a cyclo-oxygenase-dependent mechanism.
Frick KK; Bushinsky DA
J Bone Miner Res; 2003 Jul; 18(7):1317-25. PubMed ID: 12854843
[TBL] [Abstract][Full Text] [Related]
29. Ovarian cancer G protein-coupled receptor 1 is involved in acid-induced apoptosis of endplate chondrocytes in intervertebral discs.
Yuan FL; Wang HR; Zhao MD; Yuan W; Cao L; Duan PG; Jiang YQ; Li XL; Dong J
J Bone Miner Res; 2014 Jan; 29(1):67-77. PubMed ID: 23821474
[TBL] [Abstract][Full Text] [Related]
30. OGR1 mediates the inhibitory effects of acidic environment on proliferation and angiogenesis of endothelial progenitor cells.
Ding S; Xu J; Zhang Q; Chen F; Zhang J; Gui K; Xiong M; Li B; Ruan Z; Zhao M
Cell Biol Int; 2019 Nov; 43(11):1307-1316. PubMed ID: 31115941
[TBL] [Abstract][Full Text] [Related]
31. Low-bone-mass phenotype of deficient mice for the cluster of differentiation 36 (CD36).
Kevorkova O; Martineau C; Martin-Falstrault L; Sanchez-Dardon J; Brissette L; Moreau R
PLoS One; 2013; 8(10):e77701. PubMed ID: 24204923
[TBL] [Abstract][Full Text] [Related]
32. Mechanism of acid-induced bone resorption.
Krieger NS; Frick KK; Bushinsky DA
Curr Opin Nephrol Hypertens; 2004 Jul; 13(4):423-36. PubMed ID: 15199293
[TBL] [Abstract][Full Text] [Related]
33. Extracellular acidification enhances osteoclast survival through an NFAT-independent, protein kinase C-dependent pathway.
Pereverzev A; Komarova SV; Korcok J; Armstrong S; Tremblay GB; Dixon SJ; Sims SM
Bone; 2008 Jan; 42(1):150-61. PubMed ID: 17964236
[TBL] [Abstract][Full Text] [Related]
34. Aging increases stromal/osteoblastic cell-induced osteoclastogenesis and alters the osteoclast precursor pool in the mouse.
Cao JJ; Wronski TJ; Iwaniec U; Phleger L; Kurimoto P; Boudignon B; Halloran BP
J Bone Miner Res; 2005 Sep; 20(9):1659-68. PubMed ID: 16059637
[TBL] [Abstract][Full Text] [Related]
35. Not etched in bone: the role of osteoclast proton-sensing receptors.
Ott SM
Kidney Int; 2021 Mar; 99(3):542-545. PubMed ID: 33637200
[TBL] [Abstract][Full Text] [Related]
36. Proton-sensing G-protein-coupled receptors.
Ludwig MG; Vanek M; Guerini D; Gasser JA; Jones CE; Junker U; Hofstetter H; Wolf RM; Seuwen K
Nature; 2003 Sep; 425(6953):93-8. PubMed ID: 12955148
[TBL] [Abstract][Full Text] [Related]
37. Peripheral cannabinoid receptor, CB2, regulates bone mass.
Ofek O; Karsak M; Leclerc N; Fogel M; Frenkel B; Wright K; Tam J; Attar-Namdar M; Kram V; Shohami E; Mechoulam R; Zimmer A; Bab I
Proc Natl Acad Sci U S A; 2006 Jan; 103(3):696-701. PubMed ID: 16407142
[TBL] [Abstract][Full Text] [Related]
38. Thrombin receptor deficiency leads to a high bone mass phenotype by decreasing the RANKL/OPG ratio.
Tudpor K; van der Eerden BC; Jongwattanapisan P; Roelofs JJ; van Leeuwen JP; Bindels RJ; Hoenderop JG
Bone; 2015 Mar; 72():14-22. PubMed ID: 25460576
[TBL] [Abstract][Full Text] [Related]
39. Loss of the nutrient sensor TAS1R3 leads to reduced bone resorption.
Eaton MS; Weinstein N; Newby JB; Plattes MM; Foster HE; Arthur JW; Ward TD; Shively SR; Shor R; Nathan J; Davis HM; Plotkin LI; Wauson EM; Dewar BJ; Broege A; Lowery JW
J Physiol Biochem; 2018 Feb; 74(1):3-8. PubMed ID: 29019082
[TBL] [Abstract][Full Text] [Related]
40. In vivo inhibition of osteoblastic metalloproteinases leads to increased trabecular bone mass.
Geoffroy V; Marty-Morieux C; Le Goupil N; Clement-Lacroix P; Terraz C; Frain M; Roux S; Rossert J; de Vernejoul MC
J Bone Miner Res; 2004 May; 19(5):811-22. PubMed ID: 15068505
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
